Connexin43 Containing Gap Junction Channels Facilitate HIV Bystander Toxicity: Implications in NeuroHIV

Human immunodeficiency virus-1 (HIV-1) infection compromises the central nervous system (CNS) in a significant number of infected individuals, resulting in neurological dysfunction that ranges from minor cognitive deficits to frank dementia. While macrophages/microglia are the predominant CNS cells infected by HIV, our laboratory and others have shown that HIV-infected astrocytes, although present in relatively low numbers with minimal to undetectable viral replication, play key role in NeuroAIDS pathogenesis. Our laboratory has identified that HIV “hijacks” connexin (Cx) containing channels, such as gap junctions (GJs) and hemichannels (HCs), to spread toxicity and apoptosis to uninfected cells even in the absence of active viral replication. In this study, using a murine model with an astrocyte-directed deletion of Cx43 gene (hGFAP-cre Cx43fl/fl) and control Cx43fl/fl mice, we examined whether few HIV-infected human astrocytoma cells (U87-CD4-CCR5), microinjected into the mouse cortex, can spread toxicity and apoptosis through GJ-mediated mechanisms, into the mouse cells, which are resistant to HIV infection. In the control Cx43fl/fl mice, microinjection of HIV-infected U87-CD4-CCR5 cells led to apoptosis in 84.28 ± 6.38% of mouse brain cells around the site of microinjection, whereas hGFAP-cre Cx43fl/fl mice exhibited minimal apoptosis (2.78 ± 1.55%). However, simultaneous injection of GJ blocker, 18α-glycyrrhetinic acid, and Cx43 blocking peptide along with microinjection of HIV-infected cells prevented apoptosis in Cx43fl/fl mice, demonstrating the Cx43 is essential for HIV-induced bystander toxicity. In conclusion, our findings demonstrate that Cx43 expression, and formation of GJs is essential for bystander apoptosis during HIV infection. These findings reveal novel potential therapeutic targets to reduce astrocyte-mediated bystander toxicity in HIV-infected individuals because despite low to undetectable viral replication in the CNS, Cx channels hijacked by HIV amplify viral neuropathogenesis.

[1]  E. Eugenin,et al.  Role of Connexin and Pannexin containing channels in HIV infection and NeuroAIDS , 2017, Neuroscience Letters.

[2]  A. Nath,et al.  Astrocytes as an HIV Reservoir: Mechanism of HIV Infection. , 2016, Current HIV research.

[3]  E. Eugenin,et al.  Mechanisms of HIV Neuropathogenesis: Role of Cellular Communication Systems. , 2016, Current HIV research.

[4]  V. Valcour,et al.  Cognitive Impairment and Persistent CNS Injury in Treated HIV , 2016, Current HIV/AIDS Reports.

[5]  M. Bennett,et al.  HIV-tat alters Connexin43 expression and trafficking in human astrocytes: role in NeuroAIDS , 2016, Journal of Neuroinflammation.

[6]  P. Ferdinandy,et al.  Connexin 43 is an emerging therapeutic target in ischemia/reperfusion injury, cardioprotection and neuroprotection. , 2015, Pharmacology & therapeutics.

[7]  Xue-li Yu,et al.  Connexin 43 stabilizes astrocytes in a stroke-like milieu to facilitate neuronal recovery , 2015, Acta Pharmacologica Sinica.

[8]  V. Bond,et al.  Association of Cytokines With Exosomes in the Plasma of HIV-1-Seropositive Individuals. , 2015, The Journal of infectious diseases.

[9]  Nathalie Rouach,et al.  Astroglial connexin 43 sustains glutamatergic synaptic efficacy , 2014, Philosophical Transactions of the Royal Society B: Biological Sciences.

[10]  M. Bennett,et al.  HIV increases the release of dickkopf‐1 protein from human astrocytes by a Cx43 hemichannel‐dependent mechanism , 2014, Journal of neurochemistry.

[11]  Wang Xi,et al.  Astrocyte‐restricted disruption of connexin‐43 impairs neuronal plasticity in mouse barrel cortex , 2014, The European journal of neuroscience.

[12]  J. Berman,et al.  Cytochrome c dysregulation induced by HIV infection of astrocytes results in bystander apoptosis of uninfected astrocytes by an IP3 and calcium‐dependent mechanism , 2013, Journal of neurochemistry.

[13]  Wei Zhang,et al.  Biochemical and Biologic Characterization of Exosomes and Microvesicles as Facilitators of HIV-1 Infection in Macrophages , 2012, The Journal of Immunology.

[14]  M. Bennett,et al.  The Role of Gap Junction Channels During Physiologic and Pathologic Conditions of the Human Central Nervous System , 2012, Journal of Neuroimmune Pharmacology.

[15]  J. Clements,et al.  Human Immunodeficiency Virus Infection of Human Astrocytes Disrupts Blood–Brain Barrier Integrity by a Gap Junction-Dependent Mechanism , 2011, The Journal of Neuroscience.

[16]  A. Nath,et al.  Immune reconstitution inflammatory syndrome and the central nervous system. , 2011, Current opinion in neurology.

[17]  J. Clements,et al.  Eradication of HIV from the brain: reasons for pause. , 2011, AIDS.

[18]  Michael J. Taylor,et al.  HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy , 2010, Neurology.

[19]  J. Berman,et al.  Gap Junctions Mediate Human Immunodeficiency Virus-Bystander Killing in Astrocytes , 2007, The Journal of Neuroscience.

[20]  J. Becker,et al.  Updated research nosology for HIV-associated neurocognitive disorders , 2007, Neurology.

[21]  A. E. Wiencken-barger,et al.  A role for Connexin43 during neurodevelopment , 2007, Glia.

[22]  G. Fishman,et al.  Proliferation of Adult Sertoli Cells Following Conditional Knockout of the Gap Junctional Protein GJA1 (Connexin 43) in Mice1 , 2007, Biology of reproduction.

[23]  M. Churchill,et al.  Use of laser capture microdissection to detect integrated HIV-1 DNA in macrophages and astrocytes from autopsy brain tissues , 2006, Journal of NeuroVirology.

[24]  P. Simmonds,et al.  Influence of HAART on HIV-related CNS disease and neuroinflammation. , 2005, Journal of neuropathology and experimental neurology.

[25]  M. Bennett,et al.  Role of connexin-based gap junction channels and hemichannels in ischemia-induced cell death in nervous tissue , 2004, Brain Research Reviews.

[26]  K. Willecke,et al.  Astrocyte cultures from conditional connexin43‐deficient mice , 2004, Glia.

[27]  M. Bennett,et al.  New roles for astrocytes: Gap junction hemichannels have something to communicate , 2003, Trends in Neurosciences.

[28]  E. Dere,et al.  Mice with astrocyte‐directed inactivation of connexin43 exhibit increased exploratory behaviour, impaired motor capacities, and changes in brain acetylcholine levels , 2003, The European journal of neuroscience.

[29]  M. Bennett,et al.  Gap junction hemichannels in astrocytes of the CNS. , 2003, Acta physiologica Scandinavica.

[30]  U. Heinemann,et al.  Accelerated Hippocampal Spreading Depression and Enhanced Locomotory Activity in Mice with Astrocyte-Directed Inactivation of Connexin43 , 2003, The Journal of Neuroscience.

[31]  K. Willecke,et al.  hGFAP‐cre transgenic mice for manipulation of glial and neuronal function in vivo , 2001, Genesis.

[32]  K. Willecke,et al.  Endothelium‐specific replacement of the connexin43 coding region by a lacZ reporter gene , 2001, Genesis.

[33]  Anthony S. Fauci,et al.  AIDS: Re-emergence of HIV after stopping therapy , 1999, Nature.

[34]  C A Wiley,et al.  HIV mediates a productive infection of the brain. , 1999, AIDS.

[35]  M. Garber,et al.  The interaction between HIV-1 Tat and human cyclin T1 requires zinc and a critical cysteine residue that is not conserved in the murine CycT1 protein. , 1998, Genes & development.

[36]  M. Mattson,et al.  Astrocytic Gap Junctional Communication Decreases Neuronal Vulnerability to Oxidative Stress‐Induced Disruption of Ca2+ Homeostasis and Cell Death , 1998, Journal of neurochemistry.

[37]  C. Raker,et al.  Mice transgenic for human CD4 and CCR5 are susceptible to HIV infection. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[38]  J. Albert,et al.  Coreceptor usage of primary human immunodeficiency virus type 1 isolates varies according to biological phenotype , 1997, Journal of virology.

[39]  B L Langille,et al.  Cardiac malformation in neonatal mice lacking connexin43. , 1995, Science.

[40]  B. Brew,et al.  HIV-associated neurocognitive disorder. , 2018, Handbook of clinical neurology.

[41]  J. Hervé,et al.  Connexin-made channels as pharmacological targets. , 2005, Current pharmaceutical design.

[42]  Global AIDS update. , 1992, World health forum.